Dianthus Therapeutics Inc (DNTH)
24.29
-0.64
(-2.57%)
USD |
NASDAQ |
May 10, 16:00
24.36
+0.07
(+0.29%)
Pre-Market: 20:00
Dianthus Therapeutics Market Cap: 712.83M for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 10, 2024 | 712.83M |
| May 09, 2024 | 731.62M |
| May 08, 2024 | 698.75M |
| May 07, 2024 | 705.50M |
| May 06, 2024 | 701.98M |
| May 03, 2024 | 757.15M |
| May 02, 2024 | 704.62M |
| May 01, 2024 | 661.18M |
| April 30, 2024 | 626.55M |
| April 29, 2024 | 642.69M |
| April 26, 2024 | 630.96M |
| April 25, 2024 | 615.99M |
| April 24, 2024 | 625.67M |
| April 23, 2024 | 687.30M |
| April 22, 2024 | 682.02M |
| April 19, 2024 | 682.31M |
| April 18, 2024 | 693.46M |
| April 17, 2024 | 684.95M |
| April 16, 2024 | 708.43M |
| April 15, 2024 | 741.59M |
| April 12, 2024 | 759.79M |
| April 11, 2024 | 730.74M |
| April 10, 2024 | 669.69M |
| April 09, 2024 | 707.84M |
| April 08, 2024 | 692.00M |
| Date | Value |
|---|---|
| April 05, 2024 | 736.31M |
| April 04, 2024 | 725.75M |
| April 03, 2024 | 769.77M |
| April 02, 2024 | 783.27M |
| April 01, 2024 | 872.19M |
| March 28, 2024 | 880.40M |
| March 27, 2024 | 898.01M |
| March 26, 2024 | 925.01M |
| March 25, 2024 | 909.46M |
| March 22, 2024 | 937.34M |
| March 21, 2024 | 819.95M |
| March 20, 2024 | 795.30M |
| March 19, 2024 | 775.93M |
| March 18, 2024 | 773.29M |
| March 15, 2024 | 823.18M |
| March 14, 2024 | 788.55M |
| March 13, 2024 | 859.02M |
| March 12, 2024 | 737.35M |
| March 11, 2024 | 735.30M |
| March 08, 2024 | 736.77M |
| March 07, 2024 | 742.34M |
| March 06, 2024 | 732.66M |
| March 05, 2024 | 726.50M |
| March 04, 2024 | 746.44M |
| March 01, 2024 | 754.94M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
99.72M
Minimum
Dec 18 2023
937.34M
Maximum
Mar 22 2024
420.76M
Average
196.71M
Median
Market Cap Benchmarks
| Mersana Therapeutics Inc | 331.60M |
| Equillium Inc | 53.94M |
| Monopar Therapeutics Inc | 11.73M |
| Larimar Therapeutics Inc | 454.26M |
| Vera Therapeutics Inc | 2.250B |
Market Cap Related Metrics
| PS Ratio | 78.75 |
| Price to Book Value | 4.221 |
| Price | 24.29 |
| Earnings Yield | -23.47% |